Patents Assigned to The Schepens Eye Research Insititute, Inc.
  • Methods for modulating development and function of photoreceptor cells
    Patent number: 9855314
    Abstract: The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: January 2, 2018
    Assignee: The Schepens Eye Research Insititute, Inc.
    Inventor: Neena B. Haider